Search

Search Constraints

You searched for: Author/Creator Harmatz, Paul

Search Results

1. Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double‐blind, pilot study. (10th June 2015)

2. Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies. (March 2022)

3. Individual heat map assessments demonstrate vestronidase alfa treatment response in a highly heterogeneous mucopolysaccharidosis VII study population. Issue 1 (26th June 2019)

4. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy. Issue 9 (24th June 2020)

6. Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial. Issue 10252 (5th September 2020)

7. Health Related Quality of Life, Disability, and Pain in Alpha Mannosidosis: Long-Term Data of Enzyme Replacement Therapy With Velmanase Alfa (Human Recombinant Alpha Mannosidase). (3rd September 2018)

8. Increased leucocyte apoptosis in transfused β‐thalassaemia patients. (6th December 2012)

9. Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double‐blind, pilot study. (10th June 2015)

10. Morquio A Syndrome‐Associated Mutations: A Review of Alterations in the GALNS Gene and a New Locus‐Specific Database. Issue 11 (17th September 2014)